National Heart, Lung, and Blood Institute: Notice of Closed Meeting, 30314 [2016-11397]
Download as PDF
<![CDATA[
30314
Federal Register / Vol. 81, No. 94 / Monday, May 16, 2016 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued
Number of
responses per
respondent
Number of
respondents
Activity/section of FD&C Act (as amended) or FDASIA
Average
burden per
response
Total annual
responses
Total hours
Exemption
from
Profit
Prohibition
Information—
520(m)(6)(A)(i) and (ii) of the FD&C Act ..........................
Request for Determination of Eligibility Criteria—613(b) of
FDASIA .............................................................................
ADN Notification—520(m)(6)(A)(iii) of the FD&C Act ..........
ADN Modification—520(m)(6)(C) of the FD&C Act .............
3
1
3
50
150
2
1
5
1
1
1
2
1
5
10
100
100
20
100
500
Total ..............................................................................
........................
........................
........................
........................
1,370
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA’s Center for Devices and
Radiological Health receives an
estimated average of six HDE
applications per year. FDA estimates
that three of these applications will be
indicated for pediatric use. We estimate
that we will receive approximately two
requests for determination of eligibility
criteria per year. FDA estimates that
very few or no HDE holders will notify
the Agency that the number of devices
distributed in the year has exceeded the
ADN. FDA estimates that five HDE
holders will petition to have the ADN
modified due to additional information
on the number of individuals affected
by the disease or condition.
Dated: May 11, 2016.
Leslie Kux,
Associate Commissioner for Policy.
Correction
In the Federal Register of April 7,
2016, in FR Doc. 2016–07950, on page
20396, in the second column, under the
heading ‘‘II. Award Information,
Estimated Funds Available,’’ the correct
first sentence should read as follows:
The total amount of funding
identified for the current fiscal year (FY)
2016 is approximately $2,412,000.
Dated: May 4, 2016.
Mary Smith,
Principal Deputy Director, Indian Health
Service.
[FR Doc. 2016–11545 Filed 5–13–16; 8:45 am]
BILLING CODE 4165–16–P
[FR Doc. 2016–11397 Filed 5–13–16; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Heart, Lung, and Blood
Institute: Notice of Closed Meeting
National Institutes of Health
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Tribal Management Grant Program;
Correction
ACTION:
Indian Health Service, HHS.
Notice; correction.
The Indian Health Service
published a document in the Federal
Register on April 7, 2016, for the FY
2016 Tribal Management Grant Program.
The notice contained the incorrect
Fiscal Year regarding funding
availability.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Michelle Eagle Hawk, Deputy Director,
Office of Direct Service and Contracting
Tribes, Indian Health Service, 5600
Fishers Lane, Mail Stop 08E17,
Rockville, MD 20857, telephone (301)
443–1104. (This is not a toll-free
number.)
VerDate Sep<11>2014
18:48 May 13, 2016
Jkt 238001
Dated: May 10, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–11532 Filed 5–13–16; 8:45 am]
AGENCY:
Contact Person: Giuseppe Pintucci, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892, 301–435–0287,
Pintuccig@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Transition to Independence
Review Committee.
Date: June 9–10, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Virology—B Study Section.
Date: June 6–7, 2016.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\16MYN1.SGM
16MYN1
]]>Agencies
[Federal Register Volume 81, Number 94 (Monday, May 16, 2016)]
[Notices]
[Page 30314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11397]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute: Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group;
NHLBI Mentored Transition to Independence Review Committee.
Date: June 9-10, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Giuseppe Pintucci, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7192, Bethesda, MD
20892, 301-435-0287, Pintuccig@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: May 10, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-11397 Filed 5-13-16; 8:45 am]
BILLING CODE 4140-01-P
